Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1822]
News [2727]
Articles [201]
Editorials [1]
Conferences [136]
elearning [13]
Improved survival outcomes in women with HER2-negative breast cancer after...
Dr Masakazu Toi - Kyoto university, Kyoto, Japan
Improved survival outcomes in women with HER2-negative breast cancer after neoadjuvant chemotherapy ( Dr Masakazu Toi - Kyoto university, Kyoto, Japan )
10 Dec 2015
Adding carboplatin to presurgery chemotherapy improved disease-free survival...
Prof Gunter von Minckwitz - German Breast Group, Neu-Isenburg, Germany
Adding carboplatin to presurgery chemotherapy improved disease-free survival for patients with triple-negative breast cancer ( Prof Gunter von Minckwitz - German Breast Group, Neu-Isenburg, Germany )
10 Dec 2015
Women with luminal A breast cancer subtype do not seem to benefit from adjuvant...
Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada
Women with luminal A breast cancer subtype do not seem to benefit from adjuvant chemotherapy ( Dr Torsten Nielsen - University of British Columbia, Vancouver, Canada )
9 Dec 2015
Pathologic complete response to presurgery chemo improves survival for triple...
Dr William Sikov - Women & Infants Hospital of Rhode Island, Providence, USA
Pathologic complete response to presurgery chemo improves survival for triple-negative breast cancer ( Dr William Sikov - Women & Infants Hospital of Rhode Island, Providence, USA )
9 Dec 2015
Radiotherapy access in low and middle income countries
Dr Mary Gospodarowicz -Director, Princess Margaret Cancer Foundation
Radiotherapy access in low and middle income countries ( Dr Mary Gospodarowicz -Director, Princess Margaret Cancer Foundation )
8 Dec 2015
The work of the Global Academic Program in Africa
Dr Oliver Bogler - MD Anderson Cancer centre, Houston, USA
The work of the Global Academic Program in Africa ( Dr Oliver Bogler - MD Anderson Cancer centre, Houston, USA )
8 Dec 2015
ASH 2015: Latest in CLL
Prof John Gribben, Prof Stephan Stilgenbauer, Dr Alessandra Tedeschi, Dr...
ASH 2015: Latest in CLL ( Prof John Gribben, Prof Stephan Stilgenbauer, Dr Alessandra Tedeschi, Dr Patrick Thornton )
7 Dec 2015
The impact of microbiota on the immune response
Dr Giorgio Trinchieri - Center for Cancer Research, Bethesda, USA
The impact of microbiota on the immune response ( Dr Giorgio Trinchieri - Center for Cancer Research, Bethesda, USA )
7 Dec 2015
High dose chemotherapy plus transplant remains standard care for young newly...
Dr Francesca Gay - University of Torino, Torino, Italy
High dose chemotherapy plus transplant remains standard care for young newly diagnosed multiple myeloma patients ( Dr Francesca Gay - University of Torino, Torino, Italy )
7 Dec 2015
ASH 2015: Highlights in mantle cell lymphoma
Prof Simon Rule and Prof Steven Le Gouill
ASH 2015: Highlights in mantle cell lymphoma ( Prof Simon Rule and Prof Steven Le Gouill )
7 Dec 2015
Incidence of and predictors for early death in paediatric patients with acute...
Dr Oussama Abla - The Hospital for Sick Children, Toronto, Canada
Incidence of and predictors for early death in paediatric patients with acute promyelocytic leukaemia ( Dr Oussama Abla - The Hospital for Sick Children, Toronto, Canada )
6 Dec 2015
Rituximab plus chemotherapy improves outcomes in acute lymphoblastic leukaemia
Dr Sébastien Maury - Hôpital Henri Mondor, Créteil, France
Rituximab plus chemotherapy improves outcomes in acute lymphoblastic leukaemia ( Dr Sébastien Maury - Hôpital Henri Mondor, Créteil, France )
6 Dec 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation